Otonomy/ US68906L1052 /
2022-12-22 10:00:01 PM | Chg. - | Volume | Bid1:59:50 AM | Ask1:59:50 AM | High | Low |
---|---|---|---|---|---|---|
0.0770USD | - | 14.94 mill. Turnover: 970,638.9745 |
0.0840Bid Size: 383,600 | 0.0844Ask Size: 3,000 | 0.0986 | 0.0750 |
GlobeNewswire
2022-02-28
Otonomy Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update
GlobeNewswire
2022-02-22
Otonomy Completes Enrollment in Phase 2 Clinical Trial of OTO-313 in Tinnitus
GlobeNewswire
2022-02-17
Otonomy to Report Fourth Quarter and Full Year 2021 Financial Results and Provide Corporate Update
GlobeNewswire
2022-02-16
Otonomy Announces OTO-413 Presentations at American Auditory Society Annual Meeting
GlobeNewswire
2022-02-14
AGTC Announces Financial Results and Business Update for the Quarter Ended December 31, 2021
GlobeNewswire
2022-02-08
AGTC Announces Robust Improvements in Visual Sensitivity in Adult and Pediatric Patients, and Plans ...
GlobeNewswire
2022-02-07
AGTC to Host Second Quarter Financial Results Conference Call and Webcast on February 14, 2022
GlobeNewswire
2022-01-25
Otonomy Announces Multiple Presentations at Association for Research in Otolaryngology Annual Meetin...
GlobeNewswire
2022-01-11
AGTC Exceeds Enrollment Target in SKYLINE Trial of AGTC-501 for the Treatment of X-linked Retinitis ...
GlobeNewswire
2021-12-06
AGTC Appoints Biopharmaceutical Industry Leader James Robinson to its Board of Directors
GlobeNewswire
2021-11-16
Otonomy to Participate in the Piper Sandler 33rd Annual Virtual Healthcare Conference
GlobeNewswire
2021-11-12
AGTC Presents Data from Ongoing Phase 1/2 Trial of AGTC-501 at Upcoming American Academy of Ophthalm...
GlobeNewswire
2021-11-10
Otonomy Reports Third Quarter 2021 Financial Results and Provides Corporate Update